Class information for:
Level 1: STATINS//LOVASTATIN//SIMVASTATIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8340 1264 45.5 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
171 3       MONASCUS//CITRININ//MONASCUS PURPUREUS 58457
419 2             STATINS//EZETIMIBE//SIMVASTATIN 16502
8340 1                   STATINS//LOVASTATIN//SIMVASTATIN 1264

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 STATINS authKW 480761 30% 5% 382
2 LOVASTATIN authKW 244989 7% 11% 92
3 SIMVASTATIN authKW 113037 8% 5% 99
4 HMG COA REDUCTASE INHIBITORS authKW 70497 4% 5% 55
5 HYDROXYMETHYLGLUTARYL COA REDUCTASE INHIBITORS authKW 60588 2% 10% 25
6 BB BIOCYT address 54350 0% 75% 3
7 PEDIAT PNEUMONOL ALLERG DIS HEMATOL address 54350 0% 75% 3
8 MEVALONATE PATHWAY authKW 53303 2% 9% 25
9 3 HYDROXY 3 METHYL GLUTARYL COENZYME A HMG COA REDUCTASE INHIBITORS authKW 48312 0% 100% 2
10 3 HYDROXY 3 METHYL GLUTARYL COENZYME A INHIBITORS authKW 48312 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 12080 50% 0% 638
2 Urology & Nephrology 555 7% 0% 86
3 Gastroenterology & Hepatology 314 6% 0% 70
4 Pharmacology & Pharmacy 238 11% 0% 133
5 Hematology 195 5% 0% 58
6 Public, Environmental & Occupational Health 157 6% 0% 75
7 Cell Biology 153 8% 0% 97
8 Medicine, Research & Experimental 85 4% 0% 54
9 Biochemistry & Molecular Biology 35 9% 0% 119
10 Biophysics 30 3% 0% 37

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BB BIOCYT 54350 0% 75% 3
2 PEDIAT PNEUMONOL ALLERG DIS HEMATOL 54350 0% 75% 3
3 BOSTON MAV 151 48312 0% 100% 2
4 KAISER RIVERSIDE MED 48312 0% 100% 2
5 ST MED 48312 0% 100% 2
6 TAMPERE PANCREAS 32203 0% 33% 4
7 ALLERGY HLTH SCI 24156 0% 100% 1
8 ANALYT METAB CORE 24156 0% 100% 1
9 ANGIOGENESE RECH TRANSLAT INSERM EQUIPE ELLI 24156 0% 100% 1
10 ANGIOL WUPPERTAL 24156 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2555 2% 0% 26
2 CANCER PREVENTION RESEARCH 2370 1% 1% 11
3 PROSTATE CANCER AND PROSTATIC DISEASES 2223 1% 1% 10
4 CANCER CAUSES & CONTROL 2115 1% 1% 17
5 INTERNATIONAL JOURNAL OF ONCOLOGY 1546 2% 0% 25
6 INTERNATIONAL JOURNAL OF CANCER 1254 3% 0% 33
7 EXPERT OPINION ON DRUG SAFETY 1130 1% 1% 7
8 PROSTATE 1018 1% 0% 14
9 JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 934 1% 0% 10
10 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 803 1% 0% 8

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 STATINS 480761 30% 5% 382 Search STATINS Search STATINS
2 LOVASTATIN 244989 7% 11% 92 Search LOVASTATIN Search LOVASTATIN
3 SIMVASTATIN 113037 8% 5% 99 Search SIMVASTATIN Search SIMVASTATIN
4 HMG COA REDUCTASE INHIBITORS 70497 4% 5% 55 Search HMG+COA+REDUCTASE+INHIBITORS Search HMG+COA+REDUCTASE+INHIBITORS
5 HYDROXYMETHYLGLUTARYL COA REDUCTASE INHIBITORS 60588 2% 10% 25 Search HYDROXYMETHYLGLUTARYL+COA+REDUCTASE+INHIBITORS Search HYDROXYMETHYLGLUTARYL+COA+REDUCTASE+INHIBITORS
6 MEVALONATE PATHWAY 53303 2% 9% 25 Search MEVALONATE+PATHWAY Search MEVALONATE+PATHWAY
7 3 HYDROXY 3 METHYL GLUTARYL COENZYME A HMG COA REDUCTASE INHIBITORS 48312 0% 100% 2 Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+HMG+COA+REDUCTASE+INHIBITORS Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+HMG+COA+REDUCTASE+INHIBITORS
8 3 HYDROXY 3 METHYL GLUTARYL COENZYME A INHIBITORS 48312 0% 100% 2 Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+INHIBITORS Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+INHIBITORS
9 SIMVASTATIN SVA 48312 0% 100% 2 Search SIMVASTATIN+SVA Search SIMVASTATIN+SVA
10 HMG COA REDUCTASE 48107 3% 5% 38 Search HMG+COA+REDUCTASE Search HMG+COA+REDUCTASE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ALTWAIRGI, AK , (2015) STATINS ARE POTENTIAL ANTICANCEROUS AGENTS (REVIEW).ONCOLOGY REPORTS. VOL. 33. ISSUE 3. P. 1019 -1039 110 90% 16
2 PISANTI, S , PICARDI, P , CIAGLIA, E , D'ALESSANDRO, A , BIFULCO, M , (2014) NOVEL PROSPECTS OF STATINS AS THERAPEUTIC AGENTS IN CANCER.PHARMACOLOGICAL RESEARCH. VOL. 88. ISSUE . P. 84 -98 132 71% 17
3 OSMAK, M , (2012) STATINS AND CANCER: CURRENT AND FUTURE PROSPECTS.CANCER LETTERS. VOL. 324. ISSUE 1. P. 1 -12 113 72% 63
4 CHAE, YK , YOUSAF, M , MALECEK, MK , CARNEIRO, B , CHANDRA, S , KAPLAN, J , KALYAN, A , SASSANO, A , PLATANIAS, LC , GILES, F , (2015) STATINS AS ANTI-CANCER THERAPY; CAN WE TRANSLATE PRECLINICAL AND EPIDEMIOLOGIC DATA INTO CLINICAL BENEFIT?.DISCOVERY MEDICINE. VOL. 20. ISSUE 112. P. 413 -427 92 81% 1
5 JAKOBISIAK, M , GOLAB, J , (2010) STATINS CAN MODULATE EFFECTIVENESS OF ANTITUMOR THERAPEUTIC MODALITIES.MEDICINAL RESEARCH REVIEWS. VOL. 30. ISSUE 1. P. 102 -135 132 59% 20
6 LICARETE, E , SESARMAN, A , BANCIU, M , (2015) EXPLOITATION OF PLEIOTROPIC ACTIONS OF STATINS BY USING TUMOUR-TARGETED DELIVERY SYSTEMS.JOURNAL OF MICROENCAPSULATION. VOL. 32. ISSUE 7. P. 619 -631 115 58% 1
7 BOUDREAU, DM , YU, O , JOHNSON, J , (2010) STATIN USE AND CANCER RISK: A COMPREHENSIVE REVIEW.EXPERT OPINION ON DRUG SAFETY. VOL. 9. ISSUE 4. P. 603 -621 71 76% 90
8 ZEICHNER, S , MIHOS, CG , SANTANA, O , (2012) THE PLEIOTROPIC EFFECTS AND THERAPEUTIC POTENTIAL OF THE HYDROXY-METHYL-GLUTARYL-COA REDUCTASE INHIBITORS IN MALIGNANCIES: A COMPREHENSIVE REVIEW.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. VOL. 8. ISSUE 2. P. 176 -183 69 84% 15
9 CORCOS, L , LE JOSSIC-CORCOS, C , (2013) STATINS: PERSPECTIVES IN CANCER THERAPEUTICS.DIGESTIVE AND LIVER DISEASE. VOL. 45. ISSUE 10. P. 795-802 72 72% 12
10 MEI, ZB , LIANG, MN , LI, LZ , ZHANG, Y , WANG, QM , YANG, W , (2017) EFFECTS OF STATINS ON CANCER MORTALITY AND PROGRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 95 COHORTS INCLUDING 1,111,407 INDIVIDUALS.INTERNATIONAL JOURNAL OF CANCER. VOL. 140. ISSUE 5. P. 1068 -1081 67 74% 0

Classes with closest relation at Level 1


Rank Class id link
1 16291 CLIN EXPT MED 2//TOTAL SERUM CHOLESTEROL//LOW CHOLESTEROL
2 14156 STATINS//SIMVASTATIN//P DIS TB INTERNAL MED
3 13816 HMG COA REDUCTASE//APOMINE//FOOD FUS COMPLEX
4 19663 SIMVASTATIN//STATINS//FLUVASTATIN GELATIN COMPLEX
5 7494 STATINS//RHABDOMYOLYSIS//STATIN INTOLERANCE
6 33692 HEMISPHERIC CHEMICAL DOMINANCE//MEMBRANE NA K ATPASE//DOLICHOL
7 2292 STATINS//ATORVASTATIN//HMG COA REDUCTASE INHIBITORS
8 2877 FARNESYLTRANSFERASE//FARNESYLTRANSFERASE INHIBITOR//PROTEIN FARNESYLTRANSFERASE
9 20076 PERILLYL ALCOHOL//CIRURGIA GERAL ESPECIALIZADA//DIETARY ISOPRENOIDS
10 9257 PRAVASTATIN//HMG COA REDUCTASE INHIBITORS//MEVALONIC ACID

Go to start page